Anticoagulant Activity of <i>Naja nigricollis</i> Venom is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib

Bites from elapid snakes typically result in neurotoxic symptoms in snakebite victims. Neurotoxins are, therefore, often the focus of research relating to understanding the pathogenesis of elapid bites. However, recent evidence suggests that some elapid snake venoms contain anticoagulant toxins whic...

Full description

Bibliographic Details
Main Authors: Taline D. Kazandjian, Arif Arrahman, Kristina B.M. Still, Govert W. Somsen, Freek J. Vonk, Nicholas R. Casewell, Mark C. Wilkinson, Jeroen Kool
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/13/5/302
id doaj-db8d99bd5e744e5c9a2b7c1cbd303297
record_format Article
spelling doaj-db8d99bd5e744e5c9a2b7c1cbd3032972021-04-23T23:06:39ZengMDPI AGToxins2072-66512021-04-011330230210.3390/toxins13050302Anticoagulant Activity of <i>Naja nigricollis</i> Venom is Mediated by Phospholipase A2 Toxins and Inhibited by VarespladibTaline D. Kazandjian0Arif Arrahman1Kristina B.M. Still2Govert W. Somsen3Freek J. Vonk4Nicholas R. Casewell5Mark C. Wilkinson6Jeroen Kool7Centre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UKDepartment of Chemistry and Pharmaceutical Sciences, Division of Bioanalytical Chemistry, Faculty of Sciences, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081HV Amsterdam, The NetherlandsDepartment of Chemistry and Pharmaceutical Sciences, Division of Bioanalytical Chemistry, Faculty of Sciences, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081HV Amsterdam, The NetherlandsDepartment of Chemistry and Pharmaceutical Sciences, Division of Bioanalytical Chemistry, Faculty of Sciences, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081HV Amsterdam, The NetherlandsNaturalis Biodiversity Center, Darwinweg 2, 2333CR Leiden, The NetherlandsCentre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UKCentre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UKDepartment of Chemistry and Pharmaceutical Sciences, Division of Bioanalytical Chemistry, Faculty of Sciences, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081HV Amsterdam, The NetherlandsBites from elapid snakes typically result in neurotoxic symptoms in snakebite victims. Neurotoxins are, therefore, often the focus of research relating to understanding the pathogenesis of elapid bites. However, recent evidence suggests that some elapid snake venoms contain anticoagulant toxins which may help neurotoxic components spread more rapidly. This study examines the effects of venom from the West African black-necked spitting cobra (<i>Naja nigricollis</i>) on blood coagulation and identifies potential coagulopathic toxins. An integrated RPLC-MS methodology, coupled with nanofractionation, was first used to separate venom components, followed by MS, proteomics and coagulopathic bioassays. Coagulation assays were performed on both crude and nanofractionated <i>N. nigricollis</i> venom toxins as well as PLA<sub>2</sub>s and 3FTx purified from the venom. Assays were then repeated with the addition of either the phospholipase A<sub>2</sub> inhibitor varespladib or the snake venom metalloproteinase inhibitor marimastat to assess whether either toxin inhibitor is capable of neutralizing coagulopathic venom activity. Subsequent proteomic analysis was performed on nanofractionated bioactive venom toxins using tryptic digestion followed by nanoLC-MS/MS measurements, which were then identified using Swiss-Prot and species-specific database searches. Varespladib, but not marimastat, was found to significantly reduce the anticoagulant activity of <i>N. nigricollis</i> venom and MS and proteomics analyses confirmed that the anticoagulant venom components mostly consisted of PLA<sub>2</sub> proteins. We, therefore, conclude that PLA<sub>2</sub>s are the most likely candidates responsible for anticoagulant effects stimulated by <i>N. nigricollis</i> venom.https://www.mdpi.com/2072-6651/13/5/302snakebite<i>Naja nigricollis</i>coagulopathyvarespladibmarimastatnanofractionation
collection DOAJ
language English
format Article
sources DOAJ
author Taline D. Kazandjian
Arif Arrahman
Kristina B.M. Still
Govert W. Somsen
Freek J. Vonk
Nicholas R. Casewell
Mark C. Wilkinson
Jeroen Kool
spellingShingle Taline D. Kazandjian
Arif Arrahman
Kristina B.M. Still
Govert W. Somsen
Freek J. Vonk
Nicholas R. Casewell
Mark C. Wilkinson
Jeroen Kool
Anticoagulant Activity of <i>Naja nigricollis</i> Venom is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib
Toxins
snakebite
<i>Naja nigricollis</i>
coagulopathy
varespladib
marimastat
nanofractionation
author_facet Taline D. Kazandjian
Arif Arrahman
Kristina B.M. Still
Govert W. Somsen
Freek J. Vonk
Nicholas R. Casewell
Mark C. Wilkinson
Jeroen Kool
author_sort Taline D. Kazandjian
title Anticoagulant Activity of <i>Naja nigricollis</i> Venom is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib
title_short Anticoagulant Activity of <i>Naja nigricollis</i> Venom is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib
title_full Anticoagulant Activity of <i>Naja nigricollis</i> Venom is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib
title_fullStr Anticoagulant Activity of <i>Naja nigricollis</i> Venom is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib
title_full_unstemmed Anticoagulant Activity of <i>Naja nigricollis</i> Venom is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib
title_sort anticoagulant activity of <i>naja nigricollis</i> venom is mediated by phospholipase a2 toxins and inhibited by varespladib
publisher MDPI AG
series Toxins
issn 2072-6651
publishDate 2021-04-01
description Bites from elapid snakes typically result in neurotoxic symptoms in snakebite victims. Neurotoxins are, therefore, often the focus of research relating to understanding the pathogenesis of elapid bites. However, recent evidence suggests that some elapid snake venoms contain anticoagulant toxins which may help neurotoxic components spread more rapidly. This study examines the effects of venom from the West African black-necked spitting cobra (<i>Naja nigricollis</i>) on blood coagulation and identifies potential coagulopathic toxins. An integrated RPLC-MS methodology, coupled with nanofractionation, was first used to separate venom components, followed by MS, proteomics and coagulopathic bioassays. Coagulation assays were performed on both crude and nanofractionated <i>N. nigricollis</i> venom toxins as well as PLA<sub>2</sub>s and 3FTx purified from the venom. Assays were then repeated with the addition of either the phospholipase A<sub>2</sub> inhibitor varespladib or the snake venom metalloproteinase inhibitor marimastat to assess whether either toxin inhibitor is capable of neutralizing coagulopathic venom activity. Subsequent proteomic analysis was performed on nanofractionated bioactive venom toxins using tryptic digestion followed by nanoLC-MS/MS measurements, which were then identified using Swiss-Prot and species-specific database searches. Varespladib, but not marimastat, was found to significantly reduce the anticoagulant activity of <i>N. nigricollis</i> venom and MS and proteomics analyses confirmed that the anticoagulant venom components mostly consisted of PLA<sub>2</sub> proteins. We, therefore, conclude that PLA<sub>2</sub>s are the most likely candidates responsible for anticoagulant effects stimulated by <i>N. nigricollis</i> venom.
topic snakebite
<i>Naja nigricollis</i>
coagulopathy
varespladib
marimastat
nanofractionation
url https://www.mdpi.com/2072-6651/13/5/302
work_keys_str_mv AT talinedkazandjian anticoagulantactivityofinajanigricollisivenomismediatedbyphospholipasea2toxinsandinhibitedbyvarespladib
AT arifarrahman anticoagulantactivityofinajanigricollisivenomismediatedbyphospholipasea2toxinsandinhibitedbyvarespladib
AT kristinabmstill anticoagulantactivityofinajanigricollisivenomismediatedbyphospholipasea2toxinsandinhibitedbyvarespladib
AT govertwsomsen anticoagulantactivityofinajanigricollisivenomismediatedbyphospholipasea2toxinsandinhibitedbyvarespladib
AT freekjvonk anticoagulantactivityofinajanigricollisivenomismediatedbyphospholipasea2toxinsandinhibitedbyvarespladib
AT nicholasrcasewell anticoagulantactivityofinajanigricollisivenomismediatedbyphospholipasea2toxinsandinhibitedbyvarespladib
AT markcwilkinson anticoagulantactivityofinajanigricollisivenomismediatedbyphospholipasea2toxinsandinhibitedbyvarespladib
AT jeroenkool anticoagulantactivityofinajanigricollisivenomismediatedbyphospholipasea2toxinsandinhibitedbyvarespladib
_version_ 1721512106191224832